Availability of information in drug labels for appropriate prescribing in patients with hepatic impairmentJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
Safe use of proton pump inhibitors in patients with cirrhosisBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32018-06-0731OAAI
Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver CirrhosisDRUG SAFETYIF3.82018-01-1235OAAI
未登录.png){kind=icon}
未登录
